Enzyme replacement therapy with recombinant alpha-galactosidase A in Fabry disease: Preliminary experience in patients with end-stage renal disease or post transplant.

被引：0
|
作者：
Germain, DP [1 ]
Bonfils, P [1 ]
Boutouyrie, P [1 ]
Brion, N [1 ]
Froissart, M [1 ]
Jacquot, C [1 ]
Jeunemaitre, X [1 ]
Orssaud, C [1 ]
Plouin, PF [1 ]
Richalet, B [1 ]
Toussaint, JF [1 ]
Fiessinger, JN [1 ]
机构：
[1] European Hosp Georges Pompidou, Dept Genet, Paris, France
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2001年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
2893
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [1] Enzyme replacement therapy in patients with Fabry disease and end-stage renal disease
    [J]. Nature Clinical Practice Nephrology, 2007, 3 (10): : 525 - 526
  • [2] FABRY DISEASE - OVEREXPRESSION AND CHARACTERIZATION OF HUMAN ALPHA-GALACTOSIDASE A FOR RECOMBINANT ENZYME THERAPY
    IOANNOU, YA
    BISHOP, DF
    DESNICK, RJ
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A325 - A325
  • [3] Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapy
    Isberner, Nora
    Van Daele, Ruth
    Klinker, Hartwig
    Kraus, Sabrina
    Aghai, Fatemeh
    De Vlieger, Greet
    Kuypers, Dirk
    Debaveye, Yves
    Spriet, Isabel
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (12) : 3322 - 3325
  • [4] End-stage renal disease in patients with Fabry disease
    Obrador, GT
    Ojo, A
    Thadhani, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : S144 - S146
  • [5] Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease
    Germain, Dominique P.
    Linhart, Ales
    [J]. FRONTIERS IN GENETICS, 2024, 15
  • [6] Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients
    Snyder, Grace
    Shoskes, Daniel A.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (06) : 885 - 889
  • [7] Renal replacement therapy in patients with diabetes and end-stage renal disease
    Locatelli, F
    Pozzoni, P
    Del Vecchio, L
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01): : S25 - S29
  • [8] Fabry disease (α-galactosidase A deficiency):: Renal involvement and enzyme replacement therapy
    Desnick, RJ
    Wasserstein, MP
    Banikazemi, M
    [J]. RARE KIDNEY DISEASES, 2001, 136 : 174 - 192
  • [9] Testosterone metabolism and replacement therapy in patients with end-stage renal disease
    Johansen, KL
    [J]. SEMINARS IN DIALYSIS, 2004, 17 (03) : 202 - 208
  • [10] Comparative Effectiveness of Liver Transplant Strategies for End-Stage Liver Disease Patients on Renal Replacement Therapy
    Chang, Yaojen
    Gallon, Lorenzo
    Jay, Colleen
    Shetty, Kirti
    Ho, Bing
    Levitsky, Josh
    Baker, Talia
    Ladner, Daniela
    Friedewald, John
    Abecassis, Michael
    Hazen, Gordon
    Skaro, Anton I.
    [J]. LIVER TRANSPLANTATION, 2014, 20 (09) : 1034 - 1044
12345